Jon Rasmussen

1.6k total citations · 1 hit paper
43 papers, 1.1k citations indexed

About

Jon Rasmussen is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Pharmacology. According to data from OpenAlex, Jon Rasmussen has authored 43 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Cardiology and Cardiovascular Medicine and 9 papers in Pharmacology. Recurrent topics in Jon Rasmussen's work include Hormonal and reproductive studies (15 papers), Pharmacology and Obesity Treatment (7 papers) and Muscle metabolism and nutrition (6 papers). Jon Rasmussen is often cited by papers focused on Hormonal and reproductive studies (15 papers), Pharmacology and Obesity Treatment (7 papers) and Muscle metabolism and nutrition (6 papers). Jon Rasmussen collaborates with scholars based in Denmark, France and United States. Jon Rasmussen's co-authors include Caroline Kistorp, Morten Schou, Finn Gustafsson, Jens Faber, Christian Selmer, Henrik Wiggers, Lars Videbæk, Allan Flyvbjerg, Rasmus Stilling Tougaard and Lise Tarnow and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

In The Last Decade

Jon Rasmussen

39 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Liraglutide, a Glucagon-Like Peptide-1 Analogue, on Left Ventricular Function in Stable Chronic Heart Failure Patients with and Without Diabetes (LIVE)—a Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial

2016 381 citations Anders Jorsal, Caroline Kistorp et al. European Journal of Heart Failure profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jon Rasmussen Denmark	16	722	355	276	150	146	43	1.1k
Geralyn Spollett United States	15	702 1.0×	86 0.2×	503 1.8×	93 0.6×	171 1.2×	35	1.4k
Richard F. Arakaki United States	20	853 1.2×	70 0.2×	374 1.4×	131 0.9×	324 2.2×	51	1.3k
Eleanor Lucas United States	10	179 0.2×	360 1.0×	73 0.3×	91 0.6×	71 0.5×	17	940
Mark H. Schutta United States	18	463 0.6×	210 0.6×	152 0.6×	72 0.5×	383 2.6×	28	1.0k
H Keen United Kingdom	10	587 0.8×	241 0.7×	158 0.6×	57 0.4×	138 0.9×	28	949
Aodán Tynan Ireland	8	648 0.9×	109 0.3×	147 0.5×	118 0.8×	87 0.6×	8	917
Marina Skiba Australia	16	358 0.5×	224 0.6×	131 0.5×	24 0.2×	120 0.8×	39	965
Dinesh Nagi United Kingdom	22	734 1.0×	183 0.5×	175 0.6×	64 0.4×	207 1.4×	63	1.4k
Tomi-Pekka Tuomainen Finland	6	241 0.3×	334 0.9×	90 0.3×	94 0.6×	70 0.5×	7	755
Gemma Currie United Kingdom	14	277 0.4×	267 0.8×	189 0.7×	39 0.3×	103 0.7×	22	1.0k

Countries citing papers authored by Jon Rasmussen

Since Specialization

Citations

This map shows the geographic impact of Jon Rasmussen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Rasmussen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Rasmussen more than expected).

Fields of papers citing papers by Jon Rasmussen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Rasmussen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Rasmussen. The network helps show where Jon Rasmussen may publish in the future.

Co-authorship network of co-authors of Jon Rasmussen

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Rasmussen. A scholar is included among the top collaborators of Jon Rasmussen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Rasmussen. Jon Rasmussen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rasmussen, Jon, Niels Brandt, Jan Frystyk, et al.. (2024). Coronary Microvascular Dysfunction Years After Cessation of Anabolic Androgenic Steroid Use. JAMA Network Open. 7(12). e2451013–e2451013. 4 indexed citations

Brandt, Niels, Jon Rasmussen, Morten Dalsgaard, et al.. (2023). Effect on cardiac function among patients with type 2 diabetes following high-dose mineralocorticoid receptor antagonist using echocardiography; data from the MIRAD randomized clinical trial. BMC Cardiovascular Disorders. 23(1). 175–175.

Brandt, Niels, Philip Hasbak, Peter Gæde, et al.. (2022). Reduction of cardiac adipose tissue volume with short‐term empagliflozin treatment in patients with type 2 diabetes: A substudy from the SIMPLE randomized clinical trial. Diabetes Obesity and Metabolism. 25(3). 844–855. 4 indexed citations

Andersen, Andreas Breenfeldt, Glenn A. Jacobson, Jacob Bejder, et al.. (2021). An Abductive Inference Approach to Assess the Performance-Enhancing Effects of Drugs Included on the World Anti-Doping Agency Prohibited List. Sports Medicine. 51(7). 1353–1376. 14 indexed citations

Brandt, Niels, Per Lav Madsen, Jon Rasmussen, et al.. (2021). Mineralocorticoid Receptor Antagonist Improves Cardiac Structure in Type 2 Diabetes. JACC Heart Failure. 9(8). 550–558. 13 indexed citations

Rasmussen, Jon, Christian Selmer, Signe Frøssing, et al.. (2020). Endogenous Testosterone Levels Are Associated with Risk of Type 2 Diabetes in Women without Established Comorbidity. Journal of the Endocrine Society. 4(6). bvaa050–bvaa050. 18 indexed citations

Brandt, Niels, Jon Rasmussen, Julie Lyng Forman, et al.. (2020). Effect of high-dose mineralocorticoid receptor antagonist eplerenone on urinary albumin excretion in patients with type 2 diabetes and high cardiovascular risk: Data from the MIRAD trial. Diabetes & Metabolism. 47(4). 101190–101190. 20 indexed citations

Paquette, Martine, Dany Gauthier, Ann Chamberland, et al.. (2020). Circulating PCSK9 is associated with liver biomarkers and hepatic steatosis. Clinical Biochemistry. 77. 20–25. 29 indexed citations

Sidelmann, Johannes Jakobsen, Jørgen Gram, Jon Rasmussen, & Caroline Kistorp. (2020). Anabolic–Androgenic Steroid Abuse Impairs Fibrin Clot Lysis. Seminars in Thrombosis and Hemostasis. 47(1). 11–17. 8 indexed citations

10.

Rasmussen, Jon, et al.. (2019). Fibroblast Growth Factor 21 in Patients with Cardiac Cachexia: A Possible Role of Chronic Inflammation. ESC Heart Failure. 6(5). 983–991. 21 indexed citations

11.

Rasmussen, Jon, Morten Schou, Per Lav Madsen, et al.. (2018). Cardiac systolic dysfunction in past illicit users of anabolic androgenic steroids. American Heart Journal. 203. 49–56. 50 indexed citations

12.

Schou, Morten, Jon Rasmussen, Patrick Rossignol, et al.. (2018). Low N-terminal pro-brain natriuretic peptide levels are associated with non-alcoholic fatty liver disease in patients with type 2 diabetes. Diabetes & Metabolism. 45(5). 429–435. 12 indexed citations

13.

Rasmussen, Jon, Morten Schou, Per Lav Madsen, et al.. (2017). Increased blood pressure and aortic stiffness among abusers of anabolic androgenic steroids. Journal of Hypertension. 36(2). 277–285. 59 indexed citations

14.

Rasmussen, Jon, Christian Selmer, Peter Busch Østergren, et al.. (2016). Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study. PLoS ONE. 11(8). e0161208–e0161208. 123 indexed citations

15.

Jorsal, Anders, Caroline Kistorp, Pernille Holmager, et al.. (2016). Effect of Liraglutide, a Glucagon-Like Peptide-1 Analogue, on Left Ventricular Function in Stable Chronic Heart Failure Patients with and Without Diabetes (LIVE)—a Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial. European Journal of Heart Failure. 19(1). 69–77. 381 indexed citations breakdown →

16.

Schou, Morten, Kasper Iversen, Jens P. Goetze, et al.. (2015). Iron deficiency: Prevalence and relation to cardiovascular biomarkers in heart failure outpatients. International Journal of Cardiology. 195. 143–148. 14 indexed citations

17.

Rasmussen, Jon, et al.. (2014). Random blood glucose may be used to assess long‐term glycaemic control among patients with type 2 diabetes mellitus in a rural African clinical setting. Tropical Medicine & International Health. 19(12). 1515–1519. 8 indexed citations

18.

Rasmussen, Jon, Jenny Dahl Knudsen, Magnus Arpi, et al.. (2013). Relative efficacy of cefuroxime versus dicloxacillin as definitive antimicrobial therapy in methicillin-susceptible Staphylococcus aureus bacteraemia: a propensity-score adjusted retrospective cohort study. Journal of Antimicrobial Chemotherapy. 69(2). 506–514. 15 indexed citations

19.

Foss, Stein, et al.. (2004). Congruence on medication between patients and physicians involved in patient course. European Journal of Clinical Pharmacology. 59(11). 841–847. 32 indexed citations

20.

Olsen, Jørgen, et al.. (1987). [Repeated serum lipid measurements].. PubMed. 149(26). 1741–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact